48,830
edits
Difference between revisions of "IgG4-related systemic diseases"
Jump to navigation
Jump to search
IgG4-related systemic diseases (view source)
Revision as of 21:33, 17 February 2022
, 21:33, 17 February 2022no edit summary
| Line 10: | Line 10: | ||
*[[Autoimmune pancreatitis]] (lymphoplasmacytic sclerosing pancreatitis). | *[[Autoimmune pancreatitis]] (lymphoplasmacytic sclerosing pancreatitis). | ||
*Others. | *Others. | ||
==Microscopic== | |||
Features:<ref name=pmid28701054>{{cite journal |authors=Abraham M, Khosroshahi A |title=Diagnostic and treatment workup for IgG4-related disease |journal=Expert Rev Clin Immunol |volume=13 |issue=9 |pages=867–875 |date=September 2017 |pmid=28701054 |pmc=5896560 |doi=10.1080/1744666X.2017.1354698 |url=}}</ref> | |||
*At least 10 IgG4 +ve plasma cells.† | |||
*>40% of plasma cells IgG4 +ve. | |||
> 10 in some organs including pancreas and >50 in most organs and a ratio of IgG4+ to IgG+ plasma cells of > 40% | |||
Note: | |||
†Minimum number dependent on anatomical site.<ref name=pmid28701054/> | |||
==References== | ==References== | ||